Imunon Inc. (IMNN)
Imunon Statistics
Share Statistics
Imunon has 14.62M shares outstanding. The number of shares has increased by 55.52% in one year.
| Shares Outstanding | 14.62M |
| Shares Change (YoY) | 55.52% |
| Shares Change (QoQ) | 0.83% |
| Owned by Institutions (%) | 2.94% |
| Shares Floating | 13.91M |
| Failed to Deliver (FTD) Shares | 2.94K |
| FTD / Avg. Volume | 2.17% |
Short Selling Information
The latest short interest is 1.2M, so 8.27% of the outstanding shares have been sold short.
| Short Interest | 1.2M |
| Short % of Shares Out | 8.27% |
| Short % of Float | 8.29% |
| Short Ratio (days to cover) | 7.12 |
Valuation Ratios
The PE ratio is 0 and the forward PE ratio is -0.96. Imunon's PEG ratio is 0.
| PE Ratio | 0 |
| Forward PE | -0.96 |
| PS Ratio | 0 |
| Forward PS | 0.1 |
| PB Ratio | 0 |
| P/FCF Ratio | 0 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Imunon.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0, with a Debt / Equity ratio of 0.27.
| Current Ratio | 0 |
| Quick Ratio | 0 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | -0.06 |
| Debt / FCF | -0.06 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-744.81M |
| Employee Count | 25 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -22.12% in the last 52 weeks. The beta is 1.93, so Imunon's price volatility has been higher than the market average.
| Beta | 1.93 |
| 52-Week Price Change | -22.12% |
| 50-Day Moving Average | 0.91 |
| 200-Day Moving Average | 1 |
| Relative Strength Index (RSI) | 46.86 |
| Average Volume (20 Days) | 135.76K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -19.13B |
| Net Income | -18.62B |
| EBITDA | -19.13B |
| EBIT | n/a |
| Earnings Per Share (EPS) | -1618 |
Balance Sheet
The company has 5.87M in cash and 1.14B in debt, giving a net cash position of -1.13B.
| Cash & Cash Equivalents | 5.87M |
| Total Debt | 1.14B |
| Net Cash | -1.13B |
| Retained Earnings | -406.8B |
| Total Assets | 9.72M |
| Working Capital | -4.78B |
Cash Flow
In the last 12 months, operating cash flow was -18.85B and capital expenditures -29.54K, giving a free cash flow of -18.88B.
| Operating Cash Flow | -18.85B |
| Capital Expenditures | -29.54K |
| Free Cash Flow | -18.88B |
| FCF Per Share | -1640.97 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
IMNN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for IMNN is $29, which is 3195.5% higher than the current price. The consensus rating is "Buy".
| Price Target | $29 |
| Price Target Difference | 3195.5% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
Stock Splits
The last stock split was on Mar 1, 2022. It was a backward split with a ratio of 1:15.
| Last Split Date | Mar 1, 2022 |
| Split Type | backward |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | -59203.59 |
| Piotroski F-Score | 1 |